Pfizer-BioNTech Covid Vaccine Is 73% Effective In Young Children, Study Finds (Brian Bushard, Forbes Staff/Forbes Business News)

Brian Bushard, Forbes Staff / Forbes Business News
Pfizer-BioNTech Covid Vaccine Is 73% Effective In Young Children, Study Finds – The three-dose vaccine was most effective in children ages 6 months to 2 years, with a 75.8% efficacy rate, according to the study.The three-dose vaccine was most effective in children ages 6 months to 2 years, with a 75.8% efficacy rate, according to the study. …

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to our Newsletter